ArticleComputers in biology and medicine2025
Evaluating cardiac function in ex vivo heart perfusion using lumped parameter models.
Article in Computers in biology and medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Computational Model for Predicting Optimal Clinical Intervention in Pre-Operative Neonates with Transposition of the Great Arteries.Cardiovascular engineering and technology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
backgroundHeart transplant outcomes and survival depend on the ability to implant well-functioning organs, but there remain no reliable, objective measures of cardiac function prior to implantation. The lack of standardized protocols and advanced technologies results in inconsistencies and subjective assessments, increasing the risk for postoperative graft dysfunction, the leading cause of short-term morbidity and mortality after transplant. Ex-vivo heart perfusion (EVHP) provides a platform to evaluate donor hearts prior to implantation, using machine perfusion to reanimate the heart to a beating, physiologic state. The FDA-approved Organ Care System (OCS) is widely utilized for the evaluation and ex vivo preservation of hearts, particularly from donors after circulatory death (DCD). However, it does not permit a physiological assessment of heart function because, while the heart continues to beat, its chambers remain devoid of perfusate and thus are unable to perform any functional work.
methodIn this study, we developed and validated a lumped parameter mathematical model to assess donor hearts during ex-vivo perfusion, using a customized, in-house EVHP setup that allows left ventricular loading.
resultsWe demonstrate the ability of our mathematical model to accurately predict hemodynamic parameters, enabling performance analysis of hearts during EVHP. Our model generates pressure-volume loops, allowing for the computation of ejection fraction, and was verified with experimental measurements taken via echocardiography.
conclusionThis promising tool demonstrates the unique opportunity to utilize mathematical modeling in the assessment of donor hearts, streamlining their performance evaluation. Ultimately, a more accurate assessment of donor hearts on EVHP may improve our utilization of available donor hearts, addressing the donor organ shortage that continues to limit transplant capabilities.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.